Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Drug Delivery
Home
Drug Delivery
Drug Delivery
Type here to filter the list
In situ forming implants with high drug loading via microcrystal compaction for long-term release
(I-350) Combinatorial engineering of nebulized mRNA formulations for inhaled delivery to the lungs
(I-335) Chemical Activation of Piezo1 to Enhance TRAIL-induced Apoptosis in Glioblastoma Cells
(I-351) Impact of Surface Chemistry on Lipid Nanoparticle Transfection and Targeted Delivery
(I-348) Measurement of Cationic Solute Diffusion and Fixed Charge Density in Human Synovium
(H-318) Development and Characterization of Cathepsin-B Cleavable Tandem Peptides to Improve Nucleic Acid Delivery
(I-328) Immunostimulatory Nanobody-STING Agonist Conjugates to Improve Immunotherapy
(I-329) Optimization of Bipolar Microsecond Electric Pulses for Improved Electrochemotherapy
(I-324) Impact of succinate-based nanoparticles on dendritic cells activation and metabolism
(I-325) Nanoparticle endocytosis is driven by monocyte phenotype rather than nanoparticle size under high shear flow conditions.
(I-321) Distribution and Activity of Macrophage-Targeting Immunomodulatory Nanogels in Whole Blood
(F-209) Modifying lipid microbubble composition to enhance the delivery of gene-editing cargo into transfection-resistant cell types via microbubble-mediated sonoporation
(I-341) A large-scale machine learning analysis of inorganic nanoparticles in preclinical cancer research
(F-208) MR-Guided Focused Ultrasound Blood-Brain Barrier Disruption Increases Drug Delivery and Efficacy in a Diffuse Midline Glioma Mouse Model
(I-342) Cell specific vector targeting using a plug-and-play Adenovirus with molecular glue
(I-347) Targeted Drug Delivery to Human β-Cells Using Novel Nanocapsule Delivery Vehicle for T1D Treatment
(F-202) Lipid nanoparticles design for delivery of mRNA to cancer cells and cells in the tumor microenvironment
(I-345) The Extracellular Matrix as a Barrier to Adeno-Associated Viral Gene Delivery
(F-203) Impact of nanoparticles characteristics on gene-silencing siRNA delivery
(I-337) Amidine-Incorporated Degradable Lipids for Local, Systemic and Non-Liver mRNA Delivery
(F-206) Peptide-Based Nanoplatform for Cas9/guideRNA Delivery and Gene Editing
(I-338) Core material and surface chemistry of Layer-by-Layer (LbL) nanoparticles independently direct uptake, transport, and trafficking in preclinical blood-brain barrier (BBB) models
(F-205) Lysosome-directed delivery of theranostic polymersomes for GM1 gangliosidosis
(I-339) Dual targeted, layer-by-layer (LbL) electrostatically assembled nanoparticles cross the blood brain barrier to treat glioblastoma brain tumors
(E-199) Zeolitic Imidazolate Frameworks Activate Endosomal Toll-like Receptors and Potentiate Immunogenicity of SARS-CoV-2 Spike Protein Trimer
(I-340) Combinatorial Design of Siloxane-Incorporated Lipid Nanoparticles for Tissue-Specific mRNA Therapeutic Delivery
(E-198) Polymersomes as Chemotherapeutic Agents for Non-Invasive Treatment of Glioblastoma
(I-336) Enhancing mRNA-Based Therapeutic Delivery with Coacervate-Encapsulating Polymersomes
(I-333) Injectable mesocellular foam silica microparticles with a dual role of cell-recruiting scaffolds and intracellular delivery vehicles for enhanced cancer vaccine
(I-334) Brachytherapy by Elastin-Like Polypeptide Micelles Synergizes with Nanoparticle Immuno- and Chemotherapy for Treatment of Metastatic Cancer
(E-197) Investigation of Thermoresponsive and Biodegradable Nanogel Systems for RNA based Therapeutics
(I-346) A Slim, Pulse-Driven Microfluidic Patch-Pump for Insulin Delivery
(E-191) Thermal Stability of mRNA-Lipid Nanoparticles
(H-319) An Endosomal Escape Trojan Horse Platform to Improve Cytosolic Delivery of Nucleic Acids
(E-190) Tuning the tropism and infectivity of SARS-CoV-2 virus-like-particles (VLPs) for nucleic acid delivery
(I-343) Covalently Binding Programmed Cell Death Ligand-1 to Mesenchymal Stromal Cell Derived Extracellular Vesicles for the Treatment of Ocular Autoimmune Disease
(E-192) The synergistic effect of ionizable lipids allows tunability of pKa in lipid nanoparticles and increased potency
(I-344) Design and Construction of a Mechanically-Switchable Aptamer-Based Biotherapeutic Conjugate.
(E-193) Targeted Delivery and Release of a Small Molecule to the Cytoplasm of Cancer Stem Cells
(I-322) miR29 Loaded Antifibrotic Extracellular Vesicles Derived from Mesenchymal Stem Cells
(E-194) Surfactant- and crosslinker-free synthesis of self-associated sodium hyaluronate/doxorubicin (HA/DOX) nanoaggregates for cancer therapy
(I-323) Lipophilic Poly(beta-amino ester)/poly(lactic-co-glycolic acid) blends for co-delivery of small molecules and proteins to enable locoregional combination therapy of hepatocellular carcinoma
(E-196) Polymeric delivery of epigallocatechin-3-gallate for inhibition of epithelial-to-mesenchymal transition in chronic kidney disease
(H-320) Dual affinity nanoparticles for the transport of therapeutics from carrier cells to target cells under physiological flow conditions
(E-195) TRANSCRIPTOMIC INVESTIGATION OF BIOEFFECTS FROM MICROBUBBLE AND FOCUSED ULTRASOUND ASSISTED BLOOD BRAIN BARRIER DISRUPTION
(I-326) Albumin Hitchhiking siRNA to Silence MMP13 in a Guinea Pig Model of Post-traumatic Osteoarthritis
(F-225) CDK inhibition enhances intramuscular expression of self-amplifying RNA encoding monoclonal antibody
(I-330) Collagen Targeted DNA Origami Drug Delivery Platform
(F-232) A piezoelectric microneedle electroporator for simplified DNA and RNA delivery: a tolerability study in human subjects
(I-349) Endosomolytic Polymersomes Enhance Intracellular Delivery of Nucleic Acid Therapeutics for Improved Anticancer Immune Responses
(F-226) Developing a platform for induced pluripotent stem cell reprogramming through lipid nanoparticle-based mRNA delivery
(I-332) Nanoparticle targeting of mechanically modulated glycocalyx
(F-233) Delivery of Anti-microRNA-21 by Lung-Targeted Lipid Nanoparticles for Pulmonary Fibrosis Treatment
(I-331) ICAM-1 Targeted Nanocarriers for the Treatment of Peripheral Arterial Disease
(F-231) A Mathematical Model for Maximizing Drug Uptake in Low-EPR Tumors Using Different Methods of Ultrasound-mediated Drug Delivery
(E-189) Synthesis and optimization of poly(DMA-co-SBMA) polymer as a lubricous coating for microgels: Towards Application in the Treatment of Knee Osteoarthritis
(F-230) Engineering multiply adjuvanted mRNA vaccines through lipid and antigen design
(F-229) Design of a Self-assembled Oral Delivery Carrier for Therapeutic Proteins to Treat Autoimmune Diseases
(F-227) Development of a STING-activating polymer for cancer immunotherapy
(F-228) Controlling Endosomal Escape of Polymer Nanoparticles in Endothelial Cells to Maximize the Delivery of Nucleic Acids
(F-223) Development of Dual Pro-Angiogenic Agents Loaded Nanoparticles for Treatment of Peripheral Arterial Disease
(F-207) Enhanced mRNA Delivery by Macrophage Depletion
(F-222) Cooling-Triggered Release of Therapeutics from Physically Crosslinked Hydrogels
(F-221) Development of Phosphoserine-containing Zwitterionic Peptides for Reduction of Immunogenicity of Adeno-associated Virus Vector-mediated Gene Therapy
(F-204) Local Delivery of Immunomodulatory Therapeutics for Mesothelioma
(F-224) Engineering Adiponectin-Loaded Microparticles to Stimulate Stem Cells to Secrete Exosomes & Subsequent Characterization for Treatment of Metabolic Disease
(F-211) Anticancer activity of sinigrin-encapsulated chitosan-tripolyphosphate nanoparticles on myrosinase-expressing adenocarcinoma A549 cells
(F-210) Oxygen Sensitive Drug Delivery Using Hemoglobin Microbubbles
(F-212) Cytotoxicity and Proliferative Effect of Nitric Oxide Encapsulated Liposome on the Human Fibroblast Cells
(F-213) Development and Characterization of a Novel Interpenetrating Polymer Network Hydrogel for Local Drug Delivery
(E-200) Local Drug Delivery of Doxorubicin Achieves Complete Response in a Preclinical Pediatric Brain Tumor Model
(F-201) Local Drug Delivery of Doxorubicin Achieves Complete Response in a Preclinical Pediatric Brain Tumor Model
(F-214) Augmentation of Oral Immunotherapy with Tolerance-inducing Nanoparticles
(F-215) Dual Function Antibody Conjugates (DFAC) as a Photoacoustic Imaging Probes for Image-Guided Oral Cancer Therapy
(F-216) DNA-Directed Anchoring of Antibodies to Nanoparticles for Active Targeting of T Cells
(F-217) Dose-Dependent Effect of Extracellular Matrix Nanoparticles on Neutrophilic Response to Lipopolysaccharide- Induced Lung Injury
(F-220) A Targeted Stimuli-Responsive Peptide System for siRNA Delivery for Glioblastoma Multiforme Treatment
(F-219) Developing a Self-Assembling Peptide Hydrogel for Combination Drug and Gene Therapy Delivery in Glioblastoma Multiforme
(F-218) Drugamer therapeutics administered via direct pulmonary administration improve outcomes in bacterial and viral lung infections
(H-281) Studying Interactions Between PEI-DNA Polyplexes and Polymer Surface Coatings in Different Media for Localized Transfection
(H-283) Synergistic Eradication of Glioblastoma in Rodent Models by DNA-Damage through the Combined Use of Non-Ionizing Pulsed Electric Fields and Standard-of-Care Chemotherapy
(G-280) The Dose Escalation of the Local Drug Delivery in a Preclinical Pediatric Brian Tumor Model
(G-279) Thermally Stimulated Ocular Drug Delivery Enhancement: Experimentation on an Eye Model
(H-285) Viscosity-Agnostic Injection of Drug Formulations
(H-284) Utilizing Macrophages to Transport Drug Nanoparticles in Breast Cancer Liver Metastasis
(G-271) Self-photodynamic and chemodynamic anti-bacterial effects of cobalt-doped L-012 and chlorin e6-loaded CaCO3particles
(G-272) Polymeric Micelle Delivery of Cas9 Ribonucleoprotein for HEK293-GFP Gene Knockdown
(G-274) Thermogenic Modulation in Adipocytes Using Lipid Coated-Mesoporous Silica Nanoparticles
(G-273) Tunable Surface Charge on Polymeric Nanoparticles and the Effect on Endothelial Cell Drug Delivery
(G-278) Sequence Arrangement of Cationic Amphiphilic Polymers Affect Protonation Degree and their mRNA Translation
(G-277) Polymer and magnetic nanocarriers coating on Hedgehog Pathway inhibitor drugs for hyperthermia and targeting Hep 1-6 liver cancer cells
(G-275) Polymer-Assisted Light-Activatable, Sustained-Exposure Ethanol Injection Technology for Early-Stage Hepatocellular Carcinoma Treatment
(G-276) Universal mRNA-loaded immunogenic exosomes for immunotherapy of glioblastoma
(G-267) Peptoid nanotube delivery for cellular energy regeneration in brain injury
(G-268) Nanosilicate-Hydrogel Microspheres Formed by Aqueous Two-Phase Separation for Sustained Release of Small Molecules
(G-265) Nanoparticle physicochemical properties impact their association, internalization, and trafficking in sensory neurons
(G-266) Mucin–Targeted Gene Therapy for Asthma
(G-264) Formulation & Content Evaluation of Drug Loaded Buccal Films & Nanofibers
(G-269) Optimization of Multi-Adjuvant Loaded Bicontinuous Nanospheres to Elicit Group 1 CD1-Restricted T Cell Response
(G-260) Enhancing the Targeting Efficacy of Endothelial Colony Forming Cells for Renal Regeneration via Kidney-targeted Liposomal Nanoparticles
(G-261) Kidney-Targeted Gene Delivery with Polymeric Mesoscale Nanoparticles
(G-270) Stimulating Raw 264.7 Cell-Derived Exosomes Using Nanomagnets
(G-263) Injectable Granular Hydrogels Enable Avidity-Controlled Biomolecule Delivery
(G-262) Machine Learning Elucidates Design Features of Lipid Nanoparticles for Gene Delivery
(E-188) Rolling circle transcription (RCT)-based s ize-controllable RNAi modules
(J-393)
Chemical Compound Screening for BK Ion Channel
(K-431) ROS scavenging bio-origniated nanozyme and its effect on acute kidney injury
(K-432) Pre-formed vesicle-mediated delivery of messenger RNA for retinal gene therapy
(K-433)
Leveraging in silico and in vitro modeling for optimization of intrathecal AAV9 delivery to the brain: validation in nonhuman primates and translation to Rett syndrome human model phenotype
(K-434)
Machine Learning-assisted Syringe Design for Programmed mRNA-LNP Vaccine Release
(K-435)
Minimally Invasive Stromal/Platelet hybrid membrane Inspired Nanocells for Cardiac Repair
(K-436)
Controlling Protein Coronas of Polymersomes in Response to Ions
(K-437) Optimization of Polymeric Nanoparticles for siRNA Delivery
(K-438) A highly efficient nanoparticle delivery device to achieve long-term biofilm inhibition in chronic wounds
(K-439) Bio-inspired non-viral gene therapy in the mouse retina
(K-440)
Characterization of a Composite Magnetic Nanoparticle System for
In Vivo
Joint Tracking
(L-441) Transformative therapy of acute colitis with programmable micelles
(L-442)
Invasion of Jurkat Cells Conjugated with E-Selectin Modified Liposomes
(L-443)
Prolactin Protein Essential for Mammary Gland Production in Females
Sensitizes Colorectal Cancer Cells to TRAIL-mediated Apoptosis
(L-444) Local iontophoretic drug delivery into
in vitro
tumor model
(L-445)
Development of a novel emodin drug depot
(L-446) Optimizing Ionizable Lipid Tails for Liver and Non-Liver Delivery of mRNA Lipid Nanoparticles
(L-447) Novel Chitosan-Glycerol Injectable Gel for Intratumoral Delivery of Immunotherapeutics
(L-448)
Characterization of VEGF Specific Affibodies for Use in Complex Wound Healing
(L-449) Pharmacokinetics of Nerve Regenerative Polymersomes Post Sciatic Nerve Injury in Rats
(L-450)
Spatial-temporal distribution of different size agents in the brain after intranasal delivery
(L-451) Investigation of Platinum-Acridine Cancer Drug Cellular Uptake and Mechanism of Cell Death with Electrophysiology
(L-453) Characterizing Exosomes for Potential Drug Delivery Across the Blood Brain Barrier
(L-454) Passive Intrathecal Drug Delivery System
(L-455) Reduced-Cholesterol Superhydrophilic Lipid Nanoparticles for Inhaled mRNA Delivery
(L-456) Paving the Way for CAR Macrophages: A Novel Lipid-Based Therapy for Enhanced Glioblastoma Treatment
(L-457) Creation of pH Sensitive Liposomes for Drug Delivery
(L-458) Pro-Inflammatory Peptide-nanogel Conjugates for Macrophage Immunotherapy
(L-459)
A cell-based assay and image analysis program to evaluate protein binders for EV targeting
(L-460)
Polymeric microneedle patches for controlled and systemic delivery of therapeutic nanoparticles
(L-461)
Platelet-Inspired Nanoparticles Target Implanted Intracortical Microelectrodes
(L-462)
Biomaterial-Targeting Nanoparticle Delivery for Enhanced Drug Delivery
(L-463)
Polymyxin B-modified Liposomal Ciprofloxacin for Active Targeting and Treatment of Pseudomonas aeruginosa Infections
(L-464) Controlled Delivery of Muscarinic Receptor Agonists to Aid Xerostomia After Head/Neck Radiotherapy
(L-465)
Bioactivities and Release Profiles of Atorvastatin using Keratin-based Hydrogels
(L-466)
Ionizable Lipid Nanoparticles for mRNA Delivery to Human T Cells for Enforced Homing in Bone Marrow
(L-467) Dose Dependent Response to Extracellular Matrix Nanoparticles in Lipopolysaccharide-Induced Lung Injury
(L-468)
Recombinant protein S: A step towards protein S production in a heterologous system
(L-469) Facilitating clinical implementation of intratumoral injections by developing a panel of imageable drug surrogates
(L-470)
Aerosol Lung Deposition Characteristics of Isotonic and Hypertonic Solutions in a Stochastic Lung Model
(L-471) Optimizing the Formulation of Nanobubble-based Therapeutic Delivery Systems
(L-472) Polymersomes as Chemotherapeutic Agents for Non-Invasive Treatment of Glioblastoma
(L-473)
Silicone- Refillable device for Wound Healing Optimization
(L-474) The endocytosis of the macrophage foam cell to nanoparticles based on THP-1 model
(L-475) Mucosal Tissue Bioreactor for Native Tissue Culture: Application to Cystic Fibrosis
(L-476) Antibody Targeted Lipid Nanoparticles for Selective Organ Delivery
(L-477) Characterization of a cost-effective lipid nanoparticle synthesis system to enable research and education
(L-478) Core Needle Biopsy as a Tissue Collection Method for Proteomic Analysis of Subcutaneous Tissue
(L-479)
Developing a Method to Characterize and Characterize Drug-Release Profiles Under Biologically-Relevant Conditions
(L-480) Optimizing protocell uptake in mature adipocytes based on surface charge
(M-481) Peptide Based Nanoplatform for Cas9/gRNA Ribonucleoprotein Delivery and Gene Editing
(M-482)
Microparticle Fabrication for Scaffolds with Sustained Delivery of Bioactive Factors that Promote Vascular Regeneration
(M-483) The stability and diffusion of bacteriophages in hydrogels for skin and soft tissue infections
(M-484) Pulmonary Delivery of Levofloxacin Incorporated Extracellular Matrix Nanoparticles for Cystic Fibrosis Infections
(M-485) A Modified Enzyme-Cleavable Peptide Linker on Liver-Targeted Polymeric Prodrugs for the Radical Cure of Plasmodium vivax Malaria
(M-486)
Feasibility of The Noninvasive Gene Delivery/Editing to Large Brain Areas
(M-487) Delivery of Cancer Specific CRISPR System using Fusogenic Lipid-coated Mesoporous Silica Nanoparticles
(M-488) RNA Delivery Using Metal-Organic Frameworks
In Vitro Pharmacological Modulation of PIEZO1 Channels in Frontal Cortex Neuronal Networks
